Global Perspectives and Clinical Resources on BTK Inhibitor Therapy for Patients With CLL

In this program focused on global perspectives, get up to date on key topics in the use of BTK inhibitors for treating CLL with an expert-authored interactive text module and short commentary, downloadable slides, and Interactive Decision Support Tools for CLL and BTK inhibitor AE management.

Florence Cymbalista, MD, PhD

Toby Eyre, MBChB, MD

Arnon Kater, MD, PhD

Stephan Stilgenbauer, MD

Alessandra Tedeschi, MD

IDSTs

Decision Tool

Expert Guidance for the Treatment of CLL: An International Perspective

View Decision Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with CLL with those of 5 renowned experts from the United Kingdom, France, Italy, Germany, and the Netherlands.